Association study of genes regulating opioid system in autism

Psychiatry Research

Volumn 198, Issue 1, 2012, Pages 169-170

  Čupić, Barbara ^a   Hranilovic, Dubravka ^b   Jernej, Branimir ^a   Gabrilovac, Jelka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ADULT; AUTISM; AUTOMUTILATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA ISOLATION; DSM-IV; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NOCICEPTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CROATIA; DIPEPTIDYL PEPTIDASE 4; ENKEPHALINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MUTATION; PEPTIDE HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; PROTEIN PRECURSORS; RECEPTORS, OPIOID; YOUNG ADULT;

EID: 84867143183     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.11.003     Document Type: Letter

References (10)

1. Fillingim R.M., Kaplanm L., Staut R., Ness T.J., Glower T.L., Campbell C.M., Mogil J.S., Wallace M.R. The A118 G Single nucleotide Polymorphism of the μ-Opioid Receptor Gene (OPRM1) Is Associated with Pressure Pain Sensitivity in Humans. The Journal of Pain 2005, 6:159-167.
2. Kieffer B.L., Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Progress in Neurobiology 2002, 66:285-306.
3. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., Feingold J., Mouren-Simeoni M.C., Launay J.M. Whole Blood Serotonin and Plasma Beta-Endorphin in Autistic Probands and Their First-Degree Relatives. Biological Psychiatry 1999, 45:158-163.
4. Owley T., Leventhal B.L., Cook E.H. Childhood Disorders: The Autism Spectrum Disorders. Psychiatry 2003, 174-177. Wiley, Chichester. 2nd edition. A. Tasman, J. Kay, J. Lieberman (Eds.).
5. Reichelt K.L., Knievsberg A.M. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?. Nutritional Neuroscience 2003, 6:19-28.
6. Sandman C.A., Kemp A.S. Opioid antagonists may reverse endogenous opiate "dependence" in the treatment of self-injurious behavior. Pharmaceuticals 2011, 4:366-381.
7. Shanahan, M.R., Venturini, A.J., Daiss, J.L., Friedman, A.E., 2000. "Peptide diagnostic markers for human disorders", European Patent Application EP 0 969 015 A2, 1-44.
8. Sher L. Autistic disorder and the endogenous opioid system. Medical Hypotheses 1997, 48:413-414.
9. Tordjman S., Anderson G.M., Botbol M., Brailly-Tabard S., Perez- Diaz F., Graignic R., Carlier M., Schmit G., Rolland A.C., Bonnot O., Trabado S., Roubertoux P., Bronsard G. Pain Reactivity and Plasma b-Endorphin in Children and Adolescents with Autistic Disorder. PLoS One 2009, 4(8):e5289.
10. Wang L.S., Hranilovic D., Wang K., Lindquist I.E., Yurcaba L., Bujas Petkovic Z., Gidaya N., Jernej B., Hakonarson H., Bucan M. Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia. BMC Medical Genetics 2010, 11:134-153.